From: Disease control in patients with asthma and respiratory symptoms (wheezing, cough) during sleep
ACT – 1 (n = 33) | ACT – 2 (n = 10) | ACT – 3 (n = 12) | |||||
---|---|---|---|---|---|---|---|
Median | Min – Max | Median | Min – Max | Median | Min - Max | p-value (over all/ACT-1 vs 3) | |
Collective of patients | |||||||
Age | 34 | 20–63 | 38 | 23–67 | 55.5 | 30–67 | 0.003/0.001 |
Height | 172.5 | 154–200 | 167 | 159–195 | 163.5 | 156–196 | 0.217 |
Weight | 76.5 | 52–131 | 70 | 51–136 | 78.5 | 55–135 | 0.752 |
BMI | 24.8 | 17.4–36.7 | 23.7 | 18.7–47.1 | 26.7 | 21.8–40.8 | 0.443 |
PY | 0 | 0–10 | 0 | 0–10 | 1 | 0–8 | 0.389 |
ACT | 22 | 21–25 | 18 | 16–20 | 14 | 10–15 | < 0.001/< 0.001 |
LEOSound | |||||||
Median | Min – Max | Median | Min - Max | Median | Min - Max | p-value | |
Cough epoch /hour | 0 | 0–0.8 | 0.1 | 0–1.8 | 0.6 | 0–4.8 | 0.040/0.015 |
Abs Quantity coughs | 0 | 0–5 | 3 | 0–28 | 10 | 0–275 | 0.051 |
Quantity of cough /h | 0 | 0–25 | 0.4 | 0–3.5 | 1.3 | 0–34.4 | 0.049/0.017 |
Wheezing phases | 0 | 0–1 | 0 | 0–3 | 0.5 | 0–5 | < 0.001/< 0.001 |
Wheez. epoch/hour | 0 | 0–1 | 0 | 0–7.6 | 0.8 | 0–7.3 | < 0.001/< 0.001 |
Wheez. durat. [min] | 0 | 0–8.9 | 0 | 0–30.5 | 3 | 0–29 | < 0.001/< 0.001 |
Wheez. duration [%] | 0 | 0–0.9 | 0 | 0–8.1 | 0.8 | 0–6.5 | < 0.001/< 0.001 |